Our Approach to Variants
We know that COVID-19 outbreaks along with new variants will continue to dominate the lives of global citizens for the foreseeable future.
Our approach will be to create a vaccine that will elicit strong antibody responses while also generating strong T-cell responses that provide long-term immunity.
Status: To be determined in the very near future.
Strategy: Applying Providences' mRNA platform technology towards other COVID-19 variants, with an emphasis on safety and tolerability.